Trials / Completed
CompletedNCT01467349
Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan
Efficacy of Raltegravir in a Large Urban HIV Clinic Population in Milan (Efficacy of Raltegravir in a Large Urban HIV Clinic Setting)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (actual)
- Sponsor
- Università Vita-Salute San Raffaele · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This will be a retrospective analysis of efficacy, safety and tolerability of raltegravir as part of an optimized therapy in a clinical setting. Follow-up is calculated from the treatment initiation (with or without raltegravir) up to the date of discontinuation of the considered regimen or the date of last visit or the date of lost to follow-up, whichever came first. The Aim of the study is to evaluate the efficacy and safety of raltegravir-containing regimens in a urban clinic setting.
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2012-10-01
- Completion
- 2012-12-01
- First posted
- 2011-11-08
- Last updated
- 2013-02-11
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01467349. Inclusion in this directory is not an endorsement.